
LifeMD Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: people with commercial insurance who want brand-name GLP-1s plus help getting coverage
LifeMD scores highest on state availability and ease of access.
Semaglutide · oral
Price checked on LifeMD's site,
What the membership covers
Medication
Billed separately
Provider visits
Included
Shipping
Not stated
Lab work
Included
Coaching
Included
Vetted by our editors
LifeMD is a publicly traded telehealth company whose Weight Management Program pairs clinician visits, coaching and lab work with brand-name GLP-1s such as Wegovy and Zepbound. The program fee is $39 for the first month, then $149/mo, and medication is billed separately: Wegovy pill from $149, Wegovy pen from $199 and Zepbound vial from $299 self-pay, or as low as a $0-$25 copay with commercial insurance.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to LifeMD
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
LifeMD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Wegovy, Zepbound
- Starting price
- $149/mo (+ required membership)
- What's included
- Consult · Labs · Coaching
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored LifeMD
Each dimension is scored algorithmically from LifeMD'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.3/10LifeMD's brand-name medication starts at $149/mo, with a required membership or program fee billed on top. Its value score is measured against the $179 median for GLP-1 providers, which compounded programs set, so brand-name sellers score lower on value by design.
Effectiveness25%
7.7/10LifeMD offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. It prescribes FDA-approved brand-name medication rather than compounded versions. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
6.6/10Online intake and platform experience (consult included in the price); 7 platform features disclosed.
Trust & Safety15%
6.5/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
7.9/10LifeMD treats patients in all 50 states. FSA/HSA cards are accepted.
Support10%
6.4/10Coaching/dietitian access included.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this LifeMD review
Last checked October 2026- Confirmed current pricing across 3 dose/plan tiers and 1 separate fee
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $149–$299/mo across 3 dose/plan tiers, plus a $149/mo fee that excludes the medication (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with LifeMD
We walked LifeMD's public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1On the weight-management page, review starting prices (Wegovy pill $149, Wegovy pen $199, Zepbound vial $299, program fee $39 then $149/mo) and click Get Started.
- 2The quiz first asks what matters most to you (lose weight and keep it off, stop thinking about food, break a plateau, or get a clinician-guided plan).
- 3The next screen asks whether you have ever taken a GLP-1 and begins collecting your medical history.
- 4Per LifeMD's FAQ, a provider then reviews your answers, lab testing follows if you're approved, and the provider sets your treatment plan.
- Starting medication prices and the program fee are disclosed on the landing page, with footnotes saying medication prices exclude the $149/mo program fee.
- The FAQ says lab work may be required and follows approval.
- Insurance team checks GLP-1 coverage; if coverage is denied you can pay cash or cancel, but past program fees are not refunded.
- Money-back guarantee has strict conditions: 12 months of continuous enrollment, weekly weight logs and all visits and labs completed.
- The page shows 'Medicare accepted' while the FAQ says government-insured patients are not eligible for the GLP-1 program.
- The quiz offers a phone number for questions on every screen.
LifeMD customer support
- Phone
- (800) 852-1575
- info@lifemd.com
GLP-1 medications LifeMD offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
First month $39, then $149/mo. Medication is billed separately, or as low as $0-$25/mo copay with commercial insurance.
Medication only, for new patients without insurance coverage; plus the $149/mo program fee.
Medication only; plus the program fee. Ozempic pen pricing starts at the same price.
Medication only; plus the $149/mo program fee.
Ready to get started?
Plans and promotions change often, so check LifeMD's current pricing and active discounts before you decide.
What we like
- Access to brand-name GLP-1s including the Wegovy pill, Wegovy pen and Zepbound
- Insurance navigation team checks your GLP-1 coverage, with copays as low as $0-$25 for eligible patients
- Program includes clinician visits, coaching and needed lab work
- Low $39 first month for the program fee, and you can cancel anytime
- Money-back guarantee if you don't lose 10% of your weight after a year (strict terms apply)
- Publicly traded company with a broad telehealth service
Watch-outs
- The $149/mo program fee is on top of medication, so the Wegovy pill costs about $298/mo in total without insurance
- Program fees already paid are not refunded if your insurance won't cover the medication
- The money-back guarantee requires 12 months of enrollment, weekly weigh-ins and every visit and lab, and deducts program costs
- Mainly brand-name GLP-1s; compounded medication is only prescribed 'in certain situations'
- Government insurance (Medicare, Medicaid, TRICARE) patients are not eligible for the GLP-1 program, despite a 'Medicare accepted' banner
- The homepage shows a 4.9 rating with no source, while its Trustpilot rating is 3.9
LifeMD: a publicly traded, brand-first GLP-1 program
LifeMD is one of the few weight-loss telehealth companies you can look up on the stock market. As a publicly traded direct-to-patient operation, it has a real corporate entity behind your care, financial reporting it has to answer for, and a long-game incentive to keep the lights on. For people who feel uneasy handing their health to an anonymous brand they've never heard of, that visibility is the main appeal. The trade-off is that LifeMD's program is built around brand-name GLP-1 medications, which puts it on the pricier end of this market by design.
How the money works (it's a two-part bill)
Understand this before you sign up: LifeMD's pricing comes in two parts. You pay a monthly program and provider fee of $149, dropped to $39 for your first month, and that fee is completely separate from the cost of the medication itself. The program fee buys you the clinical wrapper: the prescribing clinician, ongoing visits, coaching, and lab work. The drug is billed on top of that.
For the medication, LifeMD posts self-pay starting prices for new patients without insurance coverage: the Wegovy oral pill (semaglutide) from $149 a month, the Wegovy pen from $199 (Ozempic pens start at the same price), and the Zepbound vial (tirzepatide) from $299. Add the program fee, and the cheapest cash-pay route lands at roughly double the pill price. The good news is in the fine print: with commercial insurance that covers it, LifeMD says the brand medication can drop to a copay as low as $0 to $25 a month. In that scenario the program costs far less than the cash-pay route.
What you're paying the program fee for
Unlike bargain compounding shops where you mostly pay for a vial and a quick rubber-stamp, LifeMD's monthly fee bundles in ongoing services. The program includes:
- Expert clinician consultations, physician-supervised rather than a one-and-done questionnaire
- Dedicated coaching to support the behavior-change side of weight loss
- Essential lab work, if you haven't had it done in the last 12 months
- An insurance team that checks your GLP-1 coverage
- Personalized prescriptions and ongoing dose management
Labs and coaching being baked in is something a lot of cheaper competitors skip or charge extra for. If you value the supervision and don't want to chase down your own bloodwork, you're getting something for that recurring fee beyond a prescription. Through some employers, Maven Clinic pairs brand-name GLP-1 prescriptions with metabolic specialists and nutrition support as a workplace benefit.
Brand-name first: the deliberate trade-off
This is where LifeMD splits the audience. Its program centers on FDA-approved branded medications: Wegovy as both an injection pen and the oral pill, Zepbound as a vial or KwikPen, Ozempic, Saxenda, and the newer Foundayo pill. LifeMD says a provider may prescribe compounded medication only 'in certain situations, where clinically appropriate,' and it doesn't sell a low-cost compounded plan the way many rivals do.
If you're cash-pay and uninsured, that will sting. You're paying brand prices plus the program fee, while the median cheapest monthly rate across the providers we track is $179. But if you have commercial insurance, or you simply trust an FDA-approved branded pen over a compounded formulation, the same decision is exactly what you want.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.
Who should choose LifeMD, and who should skip it
Choose LifeMD if you have commercial insurance that covers GLP-1s; the copay path is the best-case scenario here. Choose it if you specifically want brand-name Wegovy or Zepbound rather than a compound, and if a publicly traded company with built-in labs and coaching is worth a premium to you. The oral Wegovy pill also suits anyone who'd rather not inject.
Skip it if you're paying entirely out of pocket and chasing the lowest possible monthly cost; a compounding-focused provider will be much cheaper. Tuyo Health is one compounding-focused option that still includes provider visits and lab work every three months. Skip it, too, if you have Medicare, Medicaid, or TRICARE. Despite a 'Medicare accepted' banner on the site, LifeMD's own FAQ says patients with any government coverage are not eligible for its GLP-1 weight-loss program.
Refunds, the guarantee, and oversight
You can cancel anytime, but LifeMD doesn't refund program fees already charged, including when your insurance ends up denying the medication. It advertises a money-back guarantee if you don't lose 10% of your weight, but the terms are strict: 12 months of continuous enrollment, weekly weight logs, every visit and lab completed, and the refund is reduced by program costs.
On the safety ledger, there are no FDA warning letters against LifeMD, the program is physician-supervised, and its public-company status brings a level of accountability most telehealth startups can't match. One transparency note: the homepage shows a 4.9 rating with no source, while its Trustpilot rating is 3.9. State rules can also vary, so confirm the medication you want is available in your state at intake. You can see how we weigh these factors in our scoring methodology.
The bottom line
LifeMD is the commercially insured patient's GLP-1 program. If your plan covers the medication, the combination of a modest copay, a credible publicly traded operator, and included labs and coaching is hard to beat, and the $39 first month lowers the cost of finding out. If you're uninsured and price-sensitive, the brand-first approach makes it one of the more expensive routes to the same molecules, and you'll likely be happier with a compounding provider. Know which patient you are before you enroll, and the $149 monthly fee will make a lot more sense.
The Bottom Line
LifeMD scores highest on state availability and ease of access.
Ready to start with LifeMD?
From $149 a month plus a required membership. See current pricing and start your online intake.
Head-to-head
Compare LifeMD vs…
LifeMD scores7.1/10
Side-by-side pricing, medications and scores. Pick a matchup.
LifeMD vs Amazon One Medical
Amazon One Medical scores 8.5/10

LifeMD vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this LifeMD review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See LifeMD's current pricing
Plans from $149 a month plus a required membership. Start the online intake to check eligibility and today's price.